Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
0.6001
+0.0151 (2.58%)
At close: Oct 23, 2026, 4:00 PM EDT
0.6002
+0.0001 (0.02%)
Pre-market: Oct 26, 2026, 4:02 AM EDT
Biomea Fusion Stock Forecast
BMEA's stock price has decreased by -58.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Biomea Fusion stock has a consensus rating of "Buy" and an average price target of $6.17. The average 1-year stock price forecast is 927.66% higher than the current stock price, while the lowest is $4.00 (+566.56%) and the highest is $10 (+1,566.39%).
Price Target: $6.17 (+927.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Biomea Fusion stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $7 | Buy | Maintains | $7 | +1,066.47% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $4 | Buy | Maintains | $4 | +566.56% | Oct 14, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Initiates $10 | Buy | Initiates | $10 | +1,566.39% | Oct 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,066.47% | Aug 14, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +1,066.47% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.95
from -1.52
EPS Next Year
-0.94
from -0.95
EPS and Forward PE are based on non-GAAP adjusted numbers.